三联疗法治疗病毒性心肌炎临床效果

Clinical Effect of the Treatment of Viral Myocarditis With Triple Therapy

目的：分析三联疗法治疗病毒性心肌炎的临床效果。方法选取我院2012年8月-2014年8月收治的100例病毒性心肌炎患者作为本次研究的对象，随机分为对照组与观察组，每组50例患者，对照组采左卡尼汀和参麦注射液治疗，观察组采用曲美他嗪、参麦注射液与左卡尼汀三联疗法治疗，对比两组的临床治疗效果。结果在治疗后，观察组总有效率高于对照组。观察组50例患者，其中显效35例，有效12例，无效3例，总有效率为94.00%；对照组50例患者，其中显效11例，有效21例，无效18例，总有效率为64.00%，心肌功能复常时间和用药治疗总时间短于对照组，两组对比有统计学差异（P〈0.05）。结论对病毒性心肌炎患者采用三联疗法治疗，临床效果显著。

Objective To analyze the clinical effect of the treatment of viral myocarditis with triple therapy. Methods Selected 100 cases of viral myocarditis patients in our hospital from August 2012 to August 2014 as the research objects. Divided into control group and observation group randomly and averagely,each group with 50 cases,and the patients in control group were treated with L-carnitine and Shenmai injection treatment,the others in observation group were treated with Trimetazidine,Shenmai injection and levocarnitine triple therapy. Compared the two groups clinical therapeutic effects. Results The total effective rate of observation group was higher than that of control group. The total efficiency of observation group was 94%, and the total effective rate of control group was 64%. The normal time for myocardial function restores and medication treatment time in observation group were significantly shorter than these in control group. There was significant difference（P〈0.05）between two groups. Conclusion The clinical efficacy of the treatment of viral myocarditis with triple therapy is significant.